|drug2541||Saline Control Wiki||1.00|
|drug2536||STC-19 score Wiki||1.00|
|D009102||Multiple Organ Failure NIH||0.50|
|D045169||Severe Acute Respiratory Syndrome NIH||0.05|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
This study aims to use the regenerative and repair abilities of stem cells to fight against the harmful effects of the novel coronavirus Covid-19 and therefore develop a treatment strategy. It is known that fatalities from this virus is largely caused by its damage to lungs and other organs. As the disease progresses, these organs fail and lead to mortality. Our hope is that the stem cell transplantation from healthy donors will repair the damage caused by the virus and result in a healthy recovery.
Description: Improvement of clinical symptoms related to Covid-19 infection (fever, pneumonia, shortness of breath)Measure: Clinical improvement Time: 3 months
Description: Improvement of lungs assessed by CT ScanMeasure: Lung damage improvement Time: 3 months
Description: Negative, measured by RT-PCR laboratory tests for the virusMeasure: Sars-Cov-2 viral infection laboratory test Time: 3 months
Description: Cell types and numbersMeasure: Blood test Time: 3 months